Active material: Lignin gidroliznyi
When ATH: A07BC
CCF: Enterosorbent
ICD-10 codes (testimony): A02, A03, A05, K30, K72, N18, T51, T56, T88.7
When CSF: 11.10
Manufacturer: STI-MED-SORB JSC (Russia)
◊ Pills dark brown to grayish brown patches, ploskotsilindricheskoy form a facet and Valium.
| 1 tab. | |
| Lignin gidroliznyi | 400 mg |
Excipients: low molecular weight polyvinyl Medical (povidone), calcium stearate.
10 PC. – упаковки ячейковые контурные (1) – пачки картонные.
10 PC. – упаковки ячейковые контурные (2) – пачки картонные.
10 PC. – упаковки ячейковые контурные (3) – пачки картонные.
10 PC. – упаковки ячейковые контурные (5) – пачки картонные.
10 PC. – упаковки ячейковые контурные (6) – пачки картонные.
10 PC. – банки полимерные.
10 PC. – флаконы полимерные.
30 PC. – банки полимерные.
30 PC. – флаконы полимерные.
50 PC. – банки полимерные.
50 PC. – флаконы полимерные.
60 PC. – банки полимерные.
60 PC. – флаконы полимерные.
100 PC. – банки полимерные.
100 PC. – флаконы полимерные.
Enterosorbent natural origin. Состоит из продуктов гидролиза компонентов деревесины – полимера лигнина, structural elements which are derivatives of phenylpropane and hydrocellulose.
It has high sorption activity and non-specific detoxication effect. In the lumen of the gastrointestinal tract Filtrum®-STI binds and removes from the body pathogenic bacteria and bacterial toxins, medications, poisons, salts of heavy metals, alcohol, food allergens. The drug also absorbs some of the excess metabolism products (incl. bilirubin, cholesterol, urea), metabolites, responsible for the development of endogenous toxemia.
Filtirum®-STI is not toxic and is not absorbed from the gastrointestinal tract.
When administered drug is not absorbed and completely excreted through the intestine during the 24 no.
As a detoxifying agent in adults and children in the exogenous and endogenous intoxications of various origins:
- Acute poisoning by drugs, alkaloidami, salts of heavy metals, alcohol and other poisons;
- In the complex therapy of nutritional diseases, salmonelleze, dyzenteryy, dyspepsia;
- Chronic inflammatory diseases, accompanied by severe intoxication;
Hyperbilirubinemia and gïperazotemïï (hepatic and renal failure);
- Food and drug allergy;
- To prevent chronic poisoning among workers of hazardous industries.
The drug is taken orally, preferably after pre-crushing, drinking water, for 1 hour before a meal and other drug therapy.
The dose depends on the severity of the disease, age and body weight of the patient.
| Age of the patient | The average single dose |
| to 1 year | 1/2 tab. |
| from 1 Year to 3 years | 1/2-1 tab. |
| from 4 years before 7 years | 1 tab. |
| from 7 years before 12 years | 1-2 tab. |
| from 12 and older | 2-3 tab. |
Кратность приема препарата – 3-4 times / day.
If necessary, on the recommendation of a doctor daily dose can be increased to 20-30 g 3-4 admission.
Продолжительность лечения при острых состояниях – 3-5 days, при аллергических заболеваниях и хронических интоксикациях – 14-21 day.
Repeated courses of treatment in 2 week on doctor's advice.
Rarely: allergic reactions, constipation.
With prolonged use may impair the absorption of vitamins, Calcium.
- Aggravation of gastric ulcer and duodenal ulcer;
- Intestinal atony;
- Individual intolerance to the drug.
Data on the safety of the drug Filtrum®-STI during pregnancy and lactation is not available.
Chronic administration recommended prophylactic administration of multivitamins and calcium supplements.
Data on overdose are not known.
May reduce the therapeutic effect of some medicines at the same time primenyamyh.
While respecting the separate administration of the drug can be used in combination therapy with other drugs.
The drug is resolved to application as an agent Valium holidays.
The drug should be stored in a dry, protected from light, inaccessible to children at temperature not exceeding 30 ° C. Shelf life - 2 year.
This site uses cookies and services to collect technical data from visitors to ensure performance and improve the quality of service.. By continuing to use our site, you automatically agree to the use of these technologies.
Read More